KYNTRA BIO, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
KYNTRA BIO, INC. (KYNB) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -0.50% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-03-16
- KYNTRA BIO, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was -0.50%.
- KYNTRA BIO, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -0.20%.
- KYNTRA BIO, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -0.20%.
- KYNTRA BIO, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -0.20%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -0.50% 10-K · filed 2026-03-16 | |
| 2024-12-31 | -0.20% 10-K · filed 2026-03-16 | |
| 2023-12-31 | -0.20% 10-K · filed 2025-03-17 | |
| 2022-12-31 | -0.20% 10-K · filed 2024-02-26 | |
| 2021-12-31 | -0.20% 10-K · filed 2024-02-26 | -0.60% 10-K · filed 2022-02-28 |
| 2020-12-31 | -0.30% 10-K · filed 2023-02-27 | |
| 2019-12-31 | -0.60% 10-K/A · filed 2022-03-04 | |
| 2018-12-31 | -0.60% 10-K · filed 2021-03-01 | -1.10% 10-K · filed 2019-02-27 |
| 2017-12-31 | -0.30% 10-K · filed 2020-03-02 | |
| 2016-12-31 | -0.10% 10-K · filed 2019-02-27 | |
| 2015-12-31 | -0.40% 10-K · filed 2018-02-27 | |
| 2014-12-31 | 0.10% 10-K · filed 2017-03-01 | |
| 2013-12-31 | 0.20% 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |